Capecitabine and 131I-huA33 in Patients With Metastatic Colorectal Cancer

NCT00291486 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

19

Enrollment

OTHER

Sponsor class

Conditions

Colorectal Neoplasms

Interventions

DRUG: Capecitabine
DRUG: 131I-huA33 (131-Iodine on humanised monoclonal antibody A33)

Sponsor

Ludwig Institute for Cancer Research

Collaborators

[object Object]